1,091 results on '"Kage, Masayoshi"'
Search Results
202. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
203. Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.
204. Clinicopathological features of neoplasms with neuroendocrine differentiation occurring in the liver
205. The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients
206. Morphometric and cytomorphologic characterization of EGFR-mutated cancer cells-comparison between cultured lung cancer cell lines and lung adenocarcinoma clinical samples
207. A comparison of four methods for detecting KRAS mutations in formalin-fixed specimens from metastatic colorectal cancer patients
208. Su1324 Diagnostic Efficacy of Liquid Based Cytology in EUS-FNA for the Pancreatic Lesions
209. Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients
210. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy
211. Effects of 4-phenylbutyrate therapy in a preterm infant with cholestasis and liver fibrosis
212. Cytological findings of a pineal parenchymal tumor of intermediate differentiation
213. The effectiveness of combined use of liquid based cytology and conventional methods in diagnosis of Warthin tumor
214. Abstract C13: Direct binding of ERα to YB-1 suppresses HER2 expression in human breast cancer
215. Proceedings of the 26th annual meeting Chiba, Japan, October 18–20, 1984
216. Abstracts of selected papers presented at the 73rd general meeting of the Japanese Society of Gastroenterology Tokyo, Japan, April 7–9, 1987
217. Extrahepatic portal obstruction in adults: Report of an autopsy case
218. Serum <italic>Wisteria floribunda</italic> agglutinin‐positive Mac‐2 binding protein more reliably distinguishes liver fibrosis stages in non‐alcoholic fatty liver disease than serum Mac‐2 binding protein.
219. Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.
220. Characterization of urinary bile acids in a pediatric BRIC-1 patient: Effect of rifampicin treatment
221. Metastatic Pulmonary Adenocarcinoma 13 Years After Curative Resection for Pancreatic Cancer: Report of a Case and Review of Japanese Literature
222. Assessment of the ThinPrep method for endoscopic ultrasound-guided fine needle aspirates
223. An analysis of drug-induced liver injury, which showed histological findings similar to autoimmune hepatitis
224. Successful treatment with 4‐phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption
225. Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
226. High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
227. Neoplastic Spindle Cells Are an Independent Prognostic Factor in Pancreatic Cancer
228. Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance study
229. HER2-targeted Therapeutic Strategies for HER2-positive Metastatic Breast Cancers
230. Usefulness of liver fibrosis markers ELF in chronic hepatitis
231. Hepatitis B in Children -topics of the vaccination-
232. Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection
233. Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
234. Therapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis
235. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease
236. Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
237. Abstract 3662: Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through activation of M2-type macrophages by lung cancer cells
238. Abstract LB-183: Y-box binding protein-1 YB-1 negatively regulates ERα expression accompanying by enhanced HER2/ErbB2 expression in breast cancer
239. Y-Box Binding Protein-1 Activation May Modify the Responses to Endocrine and Her2-Targeted Therapeutics in Breast Cancer
240. Maximum Standardized Uptake Value on 18F-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography and Glucose Transporter-1 Expression Correlates With Survival in Invasive Ductal Carcinoma of the Pancreas
241. Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
242. Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
243. Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages
244. FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
245. An autopsy case of refractory vasculo-Behçet’s disease
246. Recent topics on portal hypertension -Start of authorization system for the technique by Japan Society for Portal Hypertension-
247. Large Blood Pressure Variability Aggravates Arteriolosclerosis and Cortical Sclerotic Changes in the Kidney in Hypertensive Rats
248. Practical Utility and Objectivity
249. A case of endometrioid adenocarcinoma with squamous differentiation was difficult to distinguish from reactive mesothelial cells in peritoneal washing cytology
250. Noninvasive Diagnosis of Liver Fibrosis: Utility of Data Mining of Both Ultrasound Elastography and Serological Findings to Construct a Decision Tree
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.